In contrast, S‐phase‐specific activation of PKCα induced senescence in non‐small cell lung cancer (NSCLC) cells, and similarly, inhibition of PKCα promoted breast cancer immune escape by maintaining the stability of programmed cell death 1 ligand 1 (PD‐L1) [39, 40]. Here, PRKCA is linked to non-small cell lung carcinoma.